Related Experiment Video
Updated: Jun 1, 2026
Methods for Culturing Human Femur Tissue Explants to Study Breast Cancer Cell Colonization of the Metastatic Niche
Published on: March 15, 2015
[Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix]
Li Wang1, Jie Wang, Demeng Yang
1School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China.
Abstract:
We performed this research mainly to explore the effect of bone sialoprotein (BSP) silence by siRNA on the adhesion ability to bone matrix of bone-seeking breast cancer cells (MDA-MB-231BO). Also we aimed to provide experimental data for prevention and treatment of breast cancer bone metastasis by targeting BSP. We explored the effects of BSP gene silence on characteristics of bone-seeking breast cancer cells: proliferation by MTS[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] assay, bone adhesion ability by a mouse bone adhesion model in vitro, morphology of the cells by SEM, and secretion of transforming growth factor-beta1 (TGF-beta1) and receptor activator of nuclear factor-kappa B ligand (RANKL) by ELISA kits. We performed intra-cardiac injection in nude mice to explore bone metastatic ability of different cell lines. The results showed that knockdown of BSP significantly inhibited the proliferation of MDA-MB-231BO cells and their adhesion to bone matrix. We also observed bone destruction caused by bone resorption around some adhering cells. The appearances of the cells changed in BSP gene silenced group, and the secretion of TGF-beta1 and RANKL decreased. The results showed BSP gene silence can partial inhibition bone metastasis of breast cancer cells in nude mice by X-ray assay and hematoxylin-eosin staining. Based on our research, siRNA-mediated BSP silencing can inhibit proliferation and adhesion to bone matrix of bone-seeking breast cancer cells and change their surface structure, thus inhibits their bone metastatic ability.
Insights
Silencing bone sialoprotein (BSP) with siRNA reduces breast cancer cell proliferation and adhesion to bone. This approach inhibits bone metastasis by altering cell characteristics and reducing key growth factor secretions.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Context:
- Breast cancer bone metastasis is a significant clinical challenge.
- Bone sialoprotein (BSP) plays a role in cancer cell adhesion and bone microenvironment interactions.
- Targeting BSP offers a potential therapeutic strategy for preventing bone metastasis.
Purpose:
- To investigate the effect of siRNA-mediated bone sialoprotein (BSP) silencing on the proliferation, bone matrix adhesion, and metastatic potential of bone-seeking breast cancer cells (MDA-MB-231BO).
- To evaluate the impact of BSP gene silencing on cellular morphology, and the secretion of transforming growth factor-beta1 (TGF-beta1) and receptor activator of nuclear factor-kappa B ligand (RANKL).
- To provide experimental evidence for targeting BSP in the prevention and treatment of breast cancer bone metastasis.
Summary:
- siRNA-mediated knockdown of BSP significantly inhibited the proliferation and bone matrix adhesion of MDA-MB-231BO cells.
- BSP gene silencing altered cell morphology and reduced the secretion of TGF-beta1 and RANKL.
- In vivo studies demonstrated that BSP gene silence partially inhibited bone metastasis of breast cancer cells in nude mice.
Impact:
- siRNA-mediated BSP silencing is a promising strategy to inhibit breast cancer cell proliferation and bone metastasis.
- Targeting BSP can alter cancer cell characteristics, including surface structure and the secretion of factors involved in bone resorption.
- This research provides a foundation for developing novel therapies against breast cancer bone metastasis.
